Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 480 participants.
Also called NCT05165251
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 480 participants
- Registry
-
NCT05165251
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT05165251. Randomized; no masking; primary purpose treatment. Start 2022-01-04 (actual); primary completion 2024-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension
- Condition
- Isolated Systolic Hypertension
- Intervention (Drug)
- Amlodipine/Atorvastatin 5 Mg-10 Mg ORAL TABLET
- Intervention (Drug)
- Amlodipine 5mg
- Intervention (Other)
- Lifestyle intervention
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
Record details
- Record id
cardio:ct-nct05165251- Content hash
e8816b4ce5e4659966fd3cc1adea675b22f13105c6a45fb63bc07167508ecd05